# Diligence obligations in an exclusive license: milestones you can actually meet

URL: https://zernyxhub.com/blog/diligence-obligations-exclusive-license
Author: Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP
Published: 2026-11-04
Category: Licensing

> Diligence obligations in an exclusive license: what ICMR and NIT Calicut require, how Section 84 and Form 27 apply, and how to set milestones you can meet.

**Short answer:** Diligence obligations are the duties an exclusive licensee accepts to develop and sell the licensed technology by agreed dates. NIT Calicut's Technology Transfer Policy 2024 generally allows a maximum of two years from licensing to commercialise. ICMR's 2024 guidelines can convert an exclusive licence to non-exclusive if the licensee fails to commercialise at scale.

Exclusivity is the most valuable thing a licensor can give, and Indian public institutions give it reluctantly. When they do, they ask for something in return: a written promise that the licensee will actually take the technology to market by certain dates. These are diligence obligations, and they decide whether your exclusive licence survives its first three years.

The trouble is that companies often accept milestones written by the licensor's office, with dates that assume nothing goes wrong. This post covers what Indian institutions require, what the law adds, and how to set milestones you can meet.

## What are diligence obligations?

They are the licensee's duties to develop, launch and keep selling. A typical set has three parts:

- Development milestones: a pilot, a validated prototype, a regulatory filing.
- Commercial milestones: first sale, a sales threshold, launch in a named territory.
- Continuing duties: keep the product on the market, report progress, file working statements.

They differ from [milestone payments](https://zernyxhub.com/blog/milestone-payments-technology-license). A milestone payment is money due when an event happens. A diligence milestone is an obligation to make the event happen, with consequences if it does not.

## What do Indian institutions require?

Two published policies show the pattern.

ICMR's [Guidelines for Technology Development Collaboration](https://www.icmr.gov.in/icmrobject/uploads/Guidelines/1732606697_icmrguidelinesfortechnologydevelopmentcollaboration.pdf) (2024) default to non-exclusive transfer; section 3.3 allows an exclusive licence only in exceptional circumstances. Section 18.2(i) lets ICMR terminate for failure to achieve milestones within the agreed timelines. Sections 14 and 15 give ICMR march-in rights if the technology is not commercialised within two years from licensing (section 15 also counts from completion of a funded project), and section 15 allows a written extension request, with reasons, where the delay has unavoidable causes. The joint development agreement template in Annexure II (section 5.4) adds that if an exclusive licensee fails to commercialise at scale, the exclusive licence may be converted into a non-exclusive one.

NIT Calicut's [Technology Transfer Policy 2024](https://nitc.ac.in/imgserver/uploads/attachments/Ed__9fcf1f03-411d-4804-bbef-6058d6c0b292_.pdf), section 10(b), generally allows a maximum of two years from licensing to commercialise. If the licensee misses it, the institute may intervene and the licensee must transfer know-how to third parties the institute names. Extension requests must be made before the period expires, with reasons. Under section 10(c), the institute can terminate after a one-month notice to cure, for missed milestones or for suspending manufacture for over a year without permission.

| Term | ICMR (2024) | NIT Calicut (2024) |
|---|---|---|
| Default licence | Non-exclusive (s.3.3) | Non-exclusive; limited exclusivity up to 5 years possible (s.9(b)) |
| Time to commercialise | March-in if not commercialised within 2 years from licensing | Generally a maximum of 2 years from licensing (s.10(b)) |
| Missed milestone | Ground for termination (s.18.2(i)) | Termination after one-month cure notice (s.10(c)) |
| Softer remedy | Exclusive may convert to non-exclusive; know-how transfer to third parties ICMR advises (s.15) | Know-how transfer to third parties named by NITC |
| Extension | Written request before the deadline, with reasons, for unavoidable delay (s.15) | Request before expiry, with reasons |

These are two institutions' rules. Others differ, but two years to market is a common expectation, and it is short for regulated products.

**Illustration: a two-year diligence window**
- Month 0, Exclusive licence signed: Clock starts
- Month 9, Pilot batch to spec: Development milestone
- Month 15, Regulatory filing made: Licensee controls the filing date
- Month 24, First commercial sale: Commercial milestone
Invented dates showing how milestones fill a two-year window.

## What does the law add?

Two provisions of the Patents Act sit behind every diligence clause.

Section 84. At any time after three years from the grant of a patent, any person interested may apply for a compulsory licence on grounds including that the invention is not worked in India or that the reasonable requirements of the public are not met. Section 84(7)(d) treats the public's requirements as unmet if the invention is not worked in India on a commercial scale to an adequate extent. An exclusive licensee that holds a patent and does nothing invites exactly this application. See [compulsory licence in India](https://zernyxhub.com/blog/compulsory-licence-india).

Section 146 and Form 27. [IP India's Form 27 FAQs](https://ipindia.gov.in/frontend/pdf/patents/1001_1_final_faqs_form-27_26thaugust2024.pdf) say every patentee and every licensee in India must file the statement of working, now once for each period of three financial years, within six months after the period ends. Exclusive and non-exclusive licensees may file separately. Non-filing may attract a penalty under section 122. Your diligence reporting to the licensor and your Form 27 should tell the same story. [Form 27 working statement](https://zernyxhub.com/blog/form-27-working-statement) covers the form itself.

## How to set milestones you can actually meet

1. Build the plan first. Work out your own realistic timeline for development, approvals and launch before you see the licensor's draft.
2. Use events you control. "Regulatory application filed" is in your hands. "Regulatory approval received" is not. Where approval is unavoidable, add an automatic extension for regulator delay.
3. Add a buffer. Put three to six months between your internal target and the contractual date.
4. Ask for a cure period. Thirty days is short for a missed technical milestone. Sixty to ninety days, with a right to propose a revised plan, is fairer.
5. Prefer conversion to termination. If you miss, losing exclusivity in one field is better than losing the licence. ICMR's own template contemplates conversion.
6. Tie the licensor's duties in. If a milestone depends on the institution's training, data or materials, say that its delay extends your date.
7. Define "commercialise". A first invoice to an unrelated customer is measurable. "Commercial scale" alone is not.

**Two ways to write the same diligence duty**
Licensor's draft:
- Obtain approval within 18 months
- Terminate on any miss
- Thirty days to cure
Balanced version:
- File application within 15 months
- Extension for regulator delay
- Convert to non-exclusive before terminating
Same goal for the licensor, far less risk for the licensee.

## A worked example with rupees

**Illustration with invented figures.** A medical consumables company takes an exclusive licence for a wound dressing from a public institute. It pays ₹12 lakh upfront and plans to spend ₹60 lakh on scale-up and testing.

| Milestone | Licensor's draft date | Negotiated date | Condition added |
|---|---|---|---|
| Pilot batch meets specification | Month 6 | Month 9 | Institute's process training completed first |
| Regulatory application filed | Month 12 | Month 15 | Licensee controls |
| First commercial sale | Month 18 | Month 24 | Plus delay for regulator time beyond 6 months |
| Missed milestone remedy | Termination | Conversion to non-exclusive | 60-day cure and revised plan |

On the original draft, a three-month slip at the regulator could have cost the company its exclusivity and the ₹72 lakh already invested. On the negotiated version, the same slip extends the date, and even a real failure costs exclusivity in the field, not the licence.

## Reporting: the duty that keeps the rest alive

Most licensors learn about a missed milestone late, and that is what turns a delay into a dispute. Offer a short written progress report every six months: what was done, what slipped, the revised date and why. Send it even when nothing is wrong. An institution that has read three honest reports is far more likely to agree an extension than one hearing about a problem for the first time in a notice. Keep the reports consistent with your sales records and your Form 27 filing, because all three may be read side by side.

## Common mistakes

- Accepting approval-based milestones with no allowance for regulator time.
- Agreeing milestones for fields or territories you have no plans to enter. Narrow the [field of use](https://zernyxhub.com/blog/field-of-use-license) instead.
- No written progress reports, so the licensor learns of a delay only when the deadline passes.
- Treating Form 27 as the patentee's job alone.
- Signing exclusivity you do not need. A non-exclusive licence carries lighter duties; [exclusive license in India](https://zernyxhub.com/blog/exclusive-licence) helps you decide.

My view is that diligence obligations are fair. A public institution should not let an exclusive licensee shelve publicly funded work. What is unfair is a date the licensee cannot control. Fix that, and the rest of the clause usually takes care of itself.

If you are comparing technologies before committing to an exclusive deal, [Zernyx Hub](https://www.zernyxhub.com) has mapped patents from universities across India, with AI business insight on each, including commercial applications.

## Common questions

### What are diligence obligations in a license agreement?

Duties the licensee accepts to develop, launch and keep selling the licensed technology: for example, a pilot by month 12, a regulatory filing by month 18 and a first sale by month 24, plus reporting on progress. They are the licensor's protection against a licensee that takes exclusivity and then shelves the technology.

### What happens if a licensee misses a diligence milestone?

Whatever the agreement says. Under NIT Calicut's policy the institute can terminate after a one-month notice to cure. Under ICMR's 2024 guidelines, failure to meet agreed milestones is a ground for termination, and an exclusive licence may be converted to non-exclusive. Negotiate cure periods and a conversion option before termination.

### Can a patent be compulsorily licensed if the licensee does not work it?

Possibly. Under section 84 of the Patents Act, any person interested may apply for a compulsory licence at any time after three years from grant, on grounds including that the invention is not worked in India. An exclusive licensee that sits on a patent exposes the patent, and its own exclusivity, to that risk.

### Does the licensee have to file Form 27?

Yes. IP India's Form 27 FAQs say every patentee and every licensee in India must file the statement of working, now once for each period of three financial years, within six months after the period ends. Non-filing may attract a penalty under section 122.

---

Published by Zernyx Hub. More: https://zernyxhub.com/llms.txt
